爱尔康
ALC87.150USD
-0.400-0.46%
交易中 （美东）报价延迟15分钟
43.10B总市值
38.49市盈率 TTM
关于 Alcon AG 公司
Alcon AG 是一家总部位于瑞士的眼科护理公司。该公司研究、开发、制造、分销和销售两大核心业务领域的全套眼科护理产品：外科和视力护理。该公司的外科业务专注于白内障手术、玻璃体视网膜手术、屈光激光手术和青光眼手术的眼科产品。外科产品组合包括这些手术所需的植入物、耗材和手术设备，并支持眼科医生的端到端需求。该公司的视力护理业务包括日抛型、可重复使用型和增色型隐形眼镜以及一系列眼部健康产品，包括用于干眼症、眼部过敏、青光眼和隐形眼镜护理的产品，以及眼部维生素和红肿缓解剂。该公司在 60 个国家开展业务，为 140 多个国家的消费者和患者提供服务。
公司简介
公司代码ALC
公司名称Alcon AG
上市日期Apr 09, 2019
成立日期2018
CEOMr. David J. Endicott
员工数量25599
证券类型Ordinary Share
年结日Apr 09
公司地址Rue Louis d'Affry 6
城市FRIBOURG
上市交易所SIX Swiss Exchange
国家Switzerland
邮编1700
电话41589113800
网址https://www.alcon.ch/
公司代码ALC
上市日期Apr 09, 2019
成立日期2018
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer
Chief Financial Officer
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer
Chief Operating Officer
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
Mr. Scott Harlan Maw
Mr. Scott Harlan Maw
Independent Director
Independent Director
17.26K
+14.57%
Ms. Ines Poeschel
Ms. Ines Poeschel
Independent Director
Independent Director
12.08K
+15.09%
Ms. Lynn Dorsey Bleil
Ms. Lynn Dorsey Bleil
Independent Director
Independent Director
10.94K
+13.26%
Mr. Leon Sergio Duplan Fraustro
Mr. Leon Sergio Duplan Fraustro
Senior Vice President, President - Americas
Senior Vice President, President - Americas
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. David J. Endicott
Mr. David J. Endicott
Chief Executive Officer, Director
Chief Executive Officer, Director
207.11K
-11.08%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Chief Financial Officer
Chief Financial Officer
134.23K
+38.34%
Mr. Rajkumar Narayanan
Mr. Rajkumar Narayanan
Senior Vice President, President - International
Senior Vice President, President - International
37.83K
+9.30%
Mr. Ian Bell
Mr. Ian Bell
Chief Operating Officer
Chief Operating Officer
30.23K
-24.88%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
28.32K
+11.14%
Mr. Laurent Attias
Mr. Laurent Attias
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
Senior Vice President - Corporate Strategy, Business Development and Licensing (BD&L) and Mergers and Acquisitions (M&A)
22.62K
+15.19%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
业务USD
名称
营收
占比
Consumables
712.00M
29.05%
Contact lenses
688.00M
28.07%
Implantables
420.00M
17.14%
Equipment/other
199.00M
8.12%
地区USD
名称
营收
占比
International
1.31B
53.61%
United States
1.14B
46.39%
业务
地区
业务USD
名称
营收
占比
Consumables
712.00M
29.05%
Contact lenses
688.00M
28.07%
Implantables
420.00M
17.14%
Equipment/other
199.00M
8.12%
股东统计
更新时间: 7月24日 周四
更新时间: 7月24日 周四
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
3.98%
Norges Bank Investment Management (NBIM)
2.53%
Aristotle Capital Management, LLC
2.45%
UBS Fund Management (Switzerland) AG
2.31%
Other
83.80%
持股股东
持股股东
占比
BlackRock Advisors (UK) Limited
4.94%
The Vanguard Group, Inc.
3.98%
Norges Bank Investment Management (NBIM)
2.53%
Aristotle Capital Management, LLC
2.45%
UBS Fund Management (Switzerland) AG
2.31%
Other
83.80%
股东类型
持股股东
占比
Investment Advisor
28.90%
Investment Advisor/Hedge Fund
25.40%
Bank and Trust
4.33%
Sovereign Wealth Fund
2.61%
Hedge Fund
2.39%
Pension Fund
1.71%
Research Firm
1.62%
Individual Investor
0.13%
Insurance Company
0.10%
Other
32.81%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
1623
337.91M
67.62%
-41.17M
2025Q1
1659
342.42M
68.52%
-42.21M
2024Q4
1636
370.45M
74.13%
+31.24M
2024Q3
1624
333.39M
66.72%
-2.12M
2024Q2
1594
337.16M
67.47%
-33.61M
2024Q1
1583
337.34M
67.51%
+4.25M
2023Q4
1598
326.79M
65.39%
-10.87M
2023Q3
1582
325.37M
65.11%
-21.48M
2023Q2
1575
329.22M
65.88%
-15.79M
2023Q1
1566
324.92M
65.02%
+2.70M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Advisors (UK) Limited
24.68M
4.94%
--
--
Dec 31, 2024
The Vanguard Group, Inc.
19.86M
3.98%
+509.47K
+2.63%
Mar 31, 2025
Norges Bank Investment Management (NBIM)
12.62M
2.53%
+276.47K
+2.24%
Dec 31, 2024
Aristotle Capital Management, LLC
12.23M
2.45%
-607.09K
-4.73%
Mar 31, 2025
UBS Fund Management (Switzerland) AG
11.54M
2.31%
-398.72K
-3.34%
Mar 31, 2025
Zürcher Kantonalbank (Asset Management)
8.51M
1.7%
-417.07K
-4.67%
Mar 31, 2025
Harding Loevner LP
7.12M
1.43%
-1.35M
-15.94%
Mar 31, 2025
AKO Capital LLP
7.12M
1.42%
+1.24M
+21.09%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
6.41M
1.28%
-8.66M
-57.46%
Mar 31, 2025
Select Equity Group, L.P.
5.48M
1.1%
-1.04M
-15.96%
Mar 31, 2025
查看更多
持股ETF
更新时间: 7月6日 周日
更新时间: 7月6日 周日
机构名称
占比
Global X Aging Population ETF
2.76%
Franklin FTSE Switzerland ETF
2.73%
iShares MSCI Switzerland ETF
2.55%
First Trust Switzerland Alphadex Fund
2.2%
Running Oak Efficient Growth ETF
1.93%
First Trust Indxx Medical Devices ETF
1.84%
Global X S&P Catholic Values Developed ex-US ETF
1.33%
BNY Mellon Women's Opportunities ETF
1.14%
Nuveen Growth Opportunities ETF
0.7%
iShares Health Innovation Active ETF
0.66%
查看更多
Global X Aging Population ETF
占比2.76%
Franklin FTSE Switzerland ETF
占比2.73%
iShares MSCI Switzerland ETF
占比2.55%
First Trust Switzerland Alphadex Fund
占比2.2%
Running Oak Efficient Growth ETF
占比1.93%
First Trust Indxx Medical Devices ETF
占比1.84%
Global X S&P Catholic Values Developed ex-US ETF
占比1.33%
BNY Mellon Women's Opportunities ETF
占比1.14%
Nuveen Growth Opportunities ETF
占比0.7%
iShares Health Innovation Active ETF
占比0.66%
分红派息
近5年累计派现
400.00M
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Mar 01, 2022
ALC.NB Final Cash Dividend of gross CHF 0.2 paid on May 05, 2022 going ex on Apr 29, 2022
May 04, 2022
May 05, 2022
May 03, 2022
Feb 24, 2021
ALC.NB Final Cash Dividend of gross CHF 0.1 paid on May 06, 2021 going ex on May 04, 2021
May 05, 2021
May 06, 2021
May 04, 2021
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
